DE1443176A1 - 6 alpha-Fluor-16-beta-methyl-4-pregnene und -1,4-pregnadiene und Verfahren zu ihrer Herstellung - Google Patents

6 alpha-Fluor-16-beta-methyl-4-pregnene und -1,4-pregnadiene und Verfahren zu ihrer Herstellung

Info

Publication number
DE1443176A1
DE1443176A1 DE19601443176 DE1443176A DE1443176A1 DE 1443176 A1 DE1443176 A1 DE 1443176A1 DE 19601443176 DE19601443176 DE 19601443176 DE 1443176 A DE1443176 A DE 1443176A DE 1443176 A1 DE1443176 A1 DE 1443176A1
Authority
DE
Germany
Prior art keywords
methyl
dione
fluoro
pregnadiene
dihydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19601443176
Other languages
German (de)
English (en)
Inventor
Spero George Basil
Lincoln Frank Harris
Schneider William Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE1443176A1 publication Critical patent/DE1443176A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19601443176 1959-03-18 1960-03-17 6 alpha-Fluor-16-beta-methyl-4-pregnene und -1,4-pregnadiene und Verfahren zu ihrer Herstellung Pending DE1443176A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80009059A 1959-03-18 1959-03-18

Publications (1)

Publication Number Publication Date
DE1443176A1 true DE1443176A1 (de) 1968-12-19

Family

ID=25177458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19601443176 Pending DE1443176A1 (de) 1959-03-18 1960-03-17 6 alpha-Fluor-16-beta-methyl-4-pregnene und -1,4-pregnadiene und Verfahren zu ihrer Herstellung

Country Status (7)

Country Link
BE (1) BE588796A (US08087162-20120103-C00010.png)
CH (2) CH397668A (US08087162-20120103-C00010.png)
DE (1) DE1443176A1 (US08087162-20120103-C00010.png)
DK (1) DK108860C (US08087162-20120103-C00010.png)
FR (2) FR1467005A (US08087162-20120103-C00010.png)
GB (2) GB898294A (US08087162-20120103-C00010.png)
SE (3) SE307352B (US08087162-20120103-C00010.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide

Also Published As

Publication number Publication date
CH397668A (de) 1965-08-31
SE312555B (US08087162-20120103-C00010.png) 1969-07-21
GB898294A (en) 1962-06-06
FR1467005A (fr) 1967-01-27
DK108860C (da) 1968-02-19
BE588796A (fr) 1960-09-19
SE307352B (US08087162-20120103-C00010.png) 1969-01-07
FR493M (US08087162-20120103-C00010.png) 1961-05-08
GB898293A (en) 1962-06-06
CH397670A (de) 1965-08-31
SE312335B (US08087162-20120103-C00010.png) 1969-07-14

Similar Documents

Publication Publication Date Title
DE1239307B (de) Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen
DE2607418A1 (de) Terpenoidester von steroiden, verfahren zu ihrer herstellung und sie enthaltende praeparate
DE3102397A1 (de) 17(alpha)-acyloxy-5(beta)-corticoide und 17(alpha)-acyloxy-5(alpha)-corticoide
DE1059906B (de) Verfahren zur Herstellung von 1, 4-Pregnadienen
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE1443176A1 (de) 6 alpha-Fluor-16-beta-methyl-4-pregnene und -1,4-pregnadiene und Verfahren zu ihrer Herstellung
DE2852055C2 (US08087162-20120103-C00010.png)
EP0039311A1 (de) Halogenierte Steroide
DE2448662C2 (de) 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1768673C (de) 6 alpha, 9 alpha-Difluorprednisolon-17,21-diester
US3131181A (en) Method of preparing 6-hydroxy pregnenes and pregnadienes and products resulting therefrom
US3163664A (en) 21-hemi-alpha, beta-dialkylsuccinates of corticoids
DE1037452B (de) Verfahren zur Herstellung von 6-Halogen-4-pregnen-11ª‰, 17ª‡, 21-triol-3, 20-dionen bzw. 6-Halogen-4-pregnen-17ª‡, 21-diol-3, 11, 20-trionen und deren 21-Acylaten
DE1158064B (de) Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen
DE1593518C3 (de) Verfahren zur Herstellung eines 17 alpha-Esters der Pregnanreihe
AT231084B (de) Verfahren zur Herstellung von in 1- und 4-Stellung ungesättigten Steroiden
DE1768673B1 (de) 6alpha,9alpha-Difluorprednisolon-17,21-diester
DE1930982A1 (de) Neue Halogenpregnadiene und ein Verfahren zu deren Herstellung
CH617709A5 (US08087162-20120103-C00010.png)
DE1058991B (de) Verfahren zur Herstellung von 6-Methyl-9ª‡-fluor-hydrocortison und 6-Methyl-9 ª‡-fluor-cortison, deren 1(2)-Dehydroverbindungen und 21-Estern
DE1189547B (de) Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen
DE1002348B (de) Verfahren zur Herstellung von oxydierten Steroiden
DE1902874A1 (de) Verfahren zur Herstellung neuer Halogenpregnadiene
DE1027668B (de) Verfahren zur Herstellung von Steroiden
DE1048915B (de) Verfahren zur Herstellung von 6-Methyl-9ª‡, 21-difluor-11ª‰, 17ª‡-dioxy-1,4-pregnadien-3,20-dion und dessen 11-Ketoanalogen